India Multiple Sclerosis Therapeutics Market (2025-2031) | Trends, Analysis, Forecast, Outlook, Share, Segmentation, Value, Growth, Industry, Size & Revenue, Companies, Competitive Landscape

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3.1 India Country Macro Economic Indicators

3.2 India Multiple Sclerosis Therapeutics Market Revenues & Volume, 2021 & 2031F

3.3 India Multiple Sclerosis Therapeutics Market - Industry Life Cycle

3.4 India Multiple Sclerosis Therapeutics Market - Porter's Five Forces

3.5 India Multiple Sclerosis Therapeutics Market Revenues & Volume Share, By Drug Class, 2021 & 2031F

3.6 India Multiple Sclerosis Therapeutics Market Revenues & Volume Share, By Mode of Administration, 2021 & 2031F

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing prevalence of multiple sclerosis in India

4.2.2 Growth in healthcare infrastructure and access to treatment options

4.2.3 Rising awareness about multiple sclerosis and its treatment

4.3 Market Restraints

4.3.1 High cost of multiple sclerosis therapeutics

4.3.2 Limited availability of advanced treatment options

4.3.3 Stringent regulatory requirements for drug approval

6.1 India Multiple Sclerosis Therapeutics Market, By Drug Class

6.1.1 Overview and Analysis

6.1.2 India Multiple Sclerosis Therapeutics Market Revenues & Volume, By Drug Class, 2021- 2031F

6.1.3 India Multiple Sclerosis Therapeutics Market Revenues & Volume, By Immunomodulators, 2021- 2031F

6.1.4 India Multiple Sclerosis Therapeutics Market Revenues & Volume, By Immunosuppressant, 2021- 2031F

6.2 India Multiple Sclerosis Therapeutics Market, By Mode of Administration

6.2.1 Overview and Analysis

6.2.2 India Multiple Sclerosis Therapeutics Market Revenues & Volume, By Oral, 2021- 2031F

6.2.3 India Multiple Sclerosis Therapeutics Market Revenues & Volume, By Injectable, 2021- 2031F

6.2.4 India Multiple Sclerosis Therapeutics Market Revenues & Volume, By Intravenous, 2021- 2031F

7.1 India Multiple Sclerosis Therapeutics Market Export to Major Countries

7.2 India Multiple Sclerosis Therapeutics Market Imports from Major Countries

8.1 Number of healthcare facilities offering multiple sclerosis treatment

8.2 Patient enrollment in clinical trials for new therapeutics

8.3 Investment in research and development for multiple sclerosis treatment options

9.1 India Multiple Sclerosis Therapeutics Market Opportunity Assessment, By Drug Class, 2021 & 2031F

9.2 India Multiple Sclerosis Therapeutics Market Opportunity Assessment, By Mode of Administration, 2021 & 2031F

10.1 India Multiple Sclerosis Therapeutics Market Revenue Share, By Companies, 2024

10.2 India Multiple Sclerosis Therapeutics Market Competitive Benchmarking, By Operating and Technical Parameters